Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499382 · ClinicalTrials.gov registry record
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00499382: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00499382 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499382 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Primary Objective: * Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).
Interventions
- PROCEDURE Nuclear Medicine Cardiac Scan
- PROCEDURE PET/CT Cardiac Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00499382
The ClinicalTrials.gov registry entry for NCT00499382 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nuclear Medicine Cardiac Scan is the first listed.
NCT00499382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00499382 about?
NCT00499382 is a clinical study titled "Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging". Primary Objective: * Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).
What is the current status of trial NCT00499382?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2004-09. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00499382?
The interventions under investigation include: Nuclear Medicine Cardiac Scan (PROCEDURE), PET/CT Cardiac Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00499382?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.